Evaxion Biotech (NASDAQ:EVAX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Evaxion Biotech (EVAX) operate in?

Evaxion Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Evaxion Biotech Stock (NASDAQ: EVAX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	2.99K / 52.88K
Day Range	- - -
52 Wk Range	1.28 - 13.61
Market Cap	$7.81M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	1.32%
Days to Cover	3.41

Recent News

Evaxion Biotech Partners With Merck To Expand Vaccine Development

Evaxion Biotech enters an expanded collaboration with Merck, granting an option to license preclinical vaccine candidates. The deal includes $3.2 million upfront and potential earnings up to $592 million based on milestone achievements.

Vandana Singh

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.

Avi Kapoor

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	2.99K / 52.88K
Day Range	- - -
52 Wk Range	1.28 - 13.61
Market Cap	$7.81M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	1.32%
Days to Cover	3.41

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Evaxion Biotech (EVAX) stock?

You can purchase shares of Evaxion Biotech (NASDAQ:EVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Evaxion Biotech (EVAX) competitors?

Other companies in Evaxion Biotech’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN) and Addex Therapeutics (NASDAQ:ADXN).

What is the forecast, or price target, for Evaxion Biotech (EVAX) stock?

Evaxion Biotech has a consensus price target of $10.00.

What is the current price for Evaxion Biotech (EVAX)?

The stock price for Evaxion Biotech (NASDAQ: EVAX) is $1.4 last updated November 21, 2024 at 9:30 AM EST.

Does Evaxion Biotech (EVAX) pay a dividend?

There are no upcoming dividends for Evaxion Biotech.

When is Evaxion Biotech (NASDAQ:EVAX) reporting earnings?

Evaxion Biotech’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Evaxion Biotech (EVAX) going to split?

There is no upcoming split for Evaxion Biotech.

What sector and industry does Evaxion Biotech (EVAX) operate in?

Evaxion Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Evaxion Biotech

Evaxion Biotech (EVAX) Forecast